MNPR MONOPAR THERAPEUTICS Product Launches 8-K Filing 2024 - New Drug Announcement Monopar Therapeutics announced that the first patient has been dosed with its new drug MNPR-101-Lu, marking a significant step in its clinical development.Get access to all SEC 8-K filings of the MONOPAR THERAPEUTICS